跳至主要内容
临床试验/NCT02905812
NCT02905812进行中(未招募)不适用

Relaxation for Critically Ill Patient Outcomes and Stress-coping Enhancement (REPOSE 1.0): Pilot Clinical Trial of an Integrative Intervention to Improve Critically Ill Patients' Delirium and Related Outcomes

University of Alberta1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2019年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
27
试验地点
1
主要终点
Feasibility 1: Recruitment rate (percentage of patients recruited among eligible patients)

研究概览

简要总结

Methodology: Pilot randomized controlled trial with 1 intervention and 1 parallel standard care group to assess the feasibility and treatment effect of a multimodal integrative intervention for delirium prevention and associated detrimental effects.

Duration: 2 years, two months. Study Center(s): Multi-center (2 sites) Aim: To assess feasibility and measures of effect of a multimodal intervention consisting of relaxation with guided imagery (RGI), and moderate pressure massage on physiological and psychological outcomes of critically ill patients.

Objectives: a) assess clinical trial feasibility with pre-defined goals (enrollment, randomization, adherence, timing of intervention, workload), b) calculate estimates and variance of treatment effect across outcome measures, c) calculate confidence intervals (CI) of incidence proportions, means and standard deviation (SD) of outcome measures in study groups., d) explore underlying physiological mechanisms of efficacy Number of Subjects: 60 participants per arm. Total: 120 participants Diagnosis and Main Inclusion Criteria: Critical illness Inclusion criteria: a) Age over 18 years, b) ICDSC:0-3. Exclusion Criteria: Patients: a) with expected ICU LOS< 72 hours, b) with acute neurological illness/ trauma, persistent sedation or coma, c) with current history of severe mental health problems and dementia, as per history and psychiatrist assessment, c) with hearing impairment or conditions not permitting use of headphones, e) on neuro-muscular blockers, f) with substance/ alcohol withdrawal, g) enrolled in trials of sedatives, antipsychotics.

Intervention: REPOSE intervention (a multimodal relaxation intervention) It includes: a) relaxation and guided imagery (RGI) (40 min, headphones), b) a brief moderate pressure massage session (massage: 15 min). RGI involves: a) guided relaxation, b) a structured guided imagery script and c) music for 15 min (Mozart piano sonata KV283, G major (2 3) II Andante). Duration of administration: Up to 5 days while participants still in the ICU.

Reference therapy: Standard care plus placebo to maintain blinding. Statistical Methodology: Outcomes will be analyzed longitudinally over 5 days by logistic regression model based on generalized estimating equations (GEE) with AR(1) correlation structure. Confidence intervals will be presented with estimated effects. Primary analysis will be based on all available data utilizing data from all assessments.

详细描述

  1. Background 1.1 Risk/Benefits Risks: Anticipated risks from participation in this study are minimal. This and similar relaxation interventions have been tested before and no inconveniences or side-effects have been reported. Adverse events, irrespective of causal relationship, will be collected for all participants Benefits: The direct benefits to participants include the opportunity to receive a relaxation intervention that has been shown helpful in terms of decreasing pain ratings and anxiety and improving quality of sleep in similar settings before.

1.2 Treatment/ Dose Rationale The evidence-based multimodal intervention (duration: 55min) is based on a literature review and the recommendations of the American Holistic Nurses Association (31) and a successful pilot (10). Multimodal integrative interventions demonstrate superior efficacy compared to uni-dimensional ones (32). It includes: a) relaxation and guided imagery (RGI) (40 min, headphones), b) a brief moderate pressure massage session (massage: 15 min). RGI involves: a) guided relaxation, b) a structured guided imagery script and c) music for 15 min (Mozart piano sonata KV283, G major (2 3) II Andante). Moderate pressure, low velocity (4 N, 1-5cm/s) massage consists of squeezing movements with wide area of contact will be applied in the following order and then reverse order, for 2-3 min at each site: over trapezius muscles, lateral arms, forearms, feet and then over the temple and forehead area. Moderate pressure massage is used as it elicits parasympathetic activation, as opposed to light pressure (33). The intervention will be administered once daily (10-11am) for up to 5 consecutive days by trained intervention nurses not involved in patient care. The intervention will start as soon as possible after ICU admission, and will be terminated upon a patient's transfer or discharge from the ICU. Selection of timing of the interventions is based on the daily schedule of the unit, to minimize interference with routine care. A 5-day intervention was selected as most patients develop delirium within the first 5 days of ICU admission (28).

1.3 Trial Conduct This study will be conducted in compliance with the protocol approved by the University of Alberta Health Research Ethics Board (HREB), and according to Good Clinical Practice standards. No deviation from the protocol will be implemented without the prior review and approval of the HREB.

Participants: Adult critically ill patients meeting the eligibility criteria.

Recruitment: Consecutive patients admitted into 2 academic teaching ICUs with Intensive Care Delirium Screening Checklist (ICDSC): 0-3 will be screened by research assistants for admission to the protocol and will be recruited by a research nurse. 2. Trial Objectives Goal: to assess clinical trial feasibility and treatment effect estimates of a multimodal intervention incorporating RGI and moderate pressure massage for prevention of ICU delirium and for improvement of physiological and psychological outcomes in critical illness. 3. Trial Design 3.1 Primary Study Endpoints/Secondary Endpoints Please see below 3.2 Study Design/Type Design: Pilot feasibility, randomized, controlled, double-blinded (clinicians, outcome assessors) trial with 2 parallel groups (intervention and standard care group). Accounting for major risk factors of delirium (28), stratified randomization according to age (<65, ≥65) and surgical or injury trauma (Trauma/ Surgery, non-Trauma/ surgery) with blocking and 1:1 allocation to assure balance in numbers per group will be employed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients hospitalized in one of the study Intensive Care Units (ICUs)
  • •Age over 18 years
  • •Intensive Care Delirium Screening Checklist (ICDSC):0-3
  • •patients enrolled in other investigative trials not involving sedative, psychoactive medications

排除标准

  • •patients with expected Intensive Care Unit length of stay < 72 hours
  • •patients with acute neurological illness/ trauma, persistent sedation or coma
  • •patients with current history of severe mental health problems and dementia, as per history and psychiatrist assessment
  • •patients with hearing impairment or conditions not permitting use of headphones
  • •patients on neuro-muscular blocker medications
  • •patients with substance/ alcohol withdrawal
  • •patients enrolled in trials of sedatives, antipsychotics

研究组 & 干预措施

Control

No Intervention

Sham intervention: Silent headphones to mask the audio component, and presence of an intervention nurse at the bedside with drawn curtains.

RGI & Massage

Active Comparator
  1. relaxation and guided imagery with background music (RGI) (40 min, headphones)
  2. a brief moderate pressure massage session (massage: 15 min)

干预措施: RGI & Massage (Other)

结局指标

主要结局

Feasibility 1: Recruitment rate (percentage of patients recruited among eligible patients)

时间窗: up to 2 years

recruitment rate (percentage of patients recruited among eligible patients)

次要结局

  • Eligibility (percentage (%) of eligible patients among patients screened)(up to 2 years)
  • Non-Consent (Percentage of eligible patients declining consent)(up to 2 years)
  • Enrollment [Time (min) from admission to enrollment](up to 2 years)
  • Protocol completion (Percentage of participants completing the entire study protocol)(Up to 25 months)
  • Delayed sessions (Percentage of intervention sessions delayed)(Up to 25 months)
  • Reasons for delayed enrollment (content analysis categories & descriptive statistics of free-text entries describing reasons for delay)(up to 2 years)
  • Missed sessions (Percentage of intervention sessions missed)(Up to 25 months)
  • Interrupted sessions (Percentage of intervention sessions interrupted)(Up to 25 months)
  • Cost [Total personnel cost ($) per participant](Up to 32 months)
  • Workload (Total personnel-hours required per participant)(Up to 32 months)
  • Duration of delirium until it is first resolved(up to 30 days)
  • Daily analgesic dose(up to 30 days)
  • Daily sedative dose (benzodiazepine equivalents)(up to 30 days)
  • Daily anti-psychotic agent dose (ml/24h)(up to 30 days)
  • Data Collection (percentage of incorrect data entries at audits)(Up to 28 months)
  • Incidence of delirium (ICDSC ≥4)(During 5 days of intervention)
  • Proportion of delirium-free time during ICU stay(up to 30 days)
  • Sedation level (RASS scale)(up to 30 days)
  • Incidence of sub-syndromal delirium (Incidence rate of ICDSC:1-3)(During 5 days of intervention)
  • Time to delirium occurrence(up to 30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验